The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex complicated organic process. Initial routes focused on peptide portion coupling, utilizing solid-phase https://theresaanvv697070.howeweb.com/41345892/synthesis-and-investigation-uses-of-retatrutide